Kangmei Pharma | 600518 - Pre Tax Profit


Kangmei Pharma reported CNY-14.01M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Genomma Lab Internacional MXN 644.1M 76.04M Mar/2026
Hypermarcas BRL 276.14M 163.07M Mar/2026
Ionis Pharmaceuticals USD -93M 135M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Jiangsu Hengrui CNY 2.56B 261.24M Mar/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Moderna USD -799M 612M Dec/2025
Organon & Co USD 213M 361M Mar/2026
Revvity USD 91.56M 35.88M Dec/2025
Sh Fosun Pharma CNY 1.27B 155.78M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -343M 335.1M Dec/2025
Wuxi Apptec CNY 5.61B 3.26B Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026